Catalyst Wire Dossier Catalyst Wire Dossier

Onradivir

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Onradivir, covering 2025-11-17 to 2025-11-17. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of Onradivir Tablets in Participants Aged 12 to 17 Years With Uncomplicated Influenza A. [Phase 3]

See pricing